NCT00403481 - An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes | Biotech Hunter

Enrollment

192

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions

Hypertension

Interventions

DRUG

olmesartan medoxomil

Olmesartan medoxomil tablets, once daily

DRUG

Olmesartan medoxomil plus Hydrochlorothiazide

Olmesartan medoxomil and hydrochlorothiazide combination tablets, once daily, if necessary

Trial Locations (27)

Birmingham

Mesa

Searcy

Los Angeles

Roseville

Tustin

DeLand

Pembroke Pines

Chicago

Wichita

Madisonville

Auburn

Baltimore

Oxon Hill

Jackson

Florissant

Williamsville

Charlotte

Winston-Salem

Cincinnati

New Talenwell

New Tazewell

Colleyville

Corpus Christi

Richardson

Murray

Norfolk